Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+
Status:
Unknown status
Trial end date:
2020-05-11
Target enrollment:
Participant gender:
Summary
Primary Objective:
To determine the 2-year distant failure rate of maintenance tegafur-uracil in patients with
squamous cell carcinoma of oral cavity with extracapsular spreading of lymph nodes.
Secondary Objectives:
- To determine the 2-year locoregional failure rate.
- To evaluate the 2-year overall survival (OS) rate.
- To evaluate the 2-year progression-free survival (PFS) rate.
- To assess the safety profiles.